3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Drug-Related Side Effects and Adverse Reactions
2
Cardiovascular Diseases
2
Cardiotoxicity
2
Prostatic Neoplasms
1
Breast Neoplasms
1
Interventions
Surveys and Questionnaires
38
Blood Specimen Collection
24
Specimen Handling
14
Radiotherapy
12
Surgical Procedures, Operative
10
Interviews as Topic
10
Observation
9
Magnetic Resonance Spectroscopy
9
Drug Therapy
9
Data Collection
8
Immunotherapy
7
Watchful Waiting
5
Tomography, X-Ray Computed
5
Radiosurgery
5
Nivolumab
5
Mastectomy, Segmental
5
Biopsy
5
ribociclib
4
palbociclib
4
Therapeutics
4
Positron Emission Tomography Computed Tomography
4
Mental Status and Dementia Tests
4
Magnetic Resonance Imaging
4
Ipilimumab
4
Immune Checkpoint Inhibitors
4
High-Throughput Nucleotide Sequencing
4
Echocardiography
4
Bevacizumab
4
lorlatinib
3
atezolizumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Observational
×
Social Determinants of Health
×
Clear all
NCT05096338
2026-03-23
PCT
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled
NCT05078190
2025-11-06
CCT2
Abramson Cancer Center at Penn Medicine
Active not recruiting
200 enrolled